Foreign Executive Witnesses Rise of Intelligent Manufacturing in east China's Jiangxi
YICHUN, China, Dec. 30, 2025 /PRNewswire/ -- A report from Jiangxi International Communication Center (JXICC): Since the beginning of the 14th Five-Year Plan, east of China's Jiangxi Province has firmly grasped the key task of achieving new-type...
RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA
HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Against the backdrop of real-world asset (RWA) digitization gradually moving from concept to practical application worldwide, Southeast Asia is emerging as a key frontier for the next wave of innovation and...
SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model
SKT consortium conducts Korean government's 'Sovereign AI Foundation Model' project with A.X K1, positioning Korea for Global Top 3 AI Powers A.X K1: Korea's first 'Teacher Model' for smaller and specialized applications SK Telecom realizes AI as...
Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined...
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology...
T-MAXIMUM Pharmaceutical's Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma
BEIJING, Dec. 21, 2025 /PRNewswire/ -- T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic, B7-H3-targeted CAR-T therapy, MT027, has received IND Clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase II...
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university BELLEVUE, Wash., Dec. 20, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH)...
Robo.ai Inc. Submits Application to Participate in the Pre-Restructuring Strategic Investor Selection of Shanghai JIDU Automobile Co., Ltd.
DUBAI, UAE, Dec. 19, 2025 /PRNewswire/ -- On December 19, 2025, Robo.ai Inc. (NASDAQ: AIIO) officially submitted its application to the provisional administrator of Shanghai JIDU Automobile Co., Ltd. (JIDU Auto), seeking to participate in its...
Shanghai a safe haven for global enterprises ahead of 15th Five-Year Plan
In the past five years, the city's cumulative utilized foreign investment reached $100.33 billion BEIJING, Dec. 19, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn: During the 14th Five-Year Plan (2021-25), foreign enterprises demonstrated...
Ranked No. 8 Globally | Wood Mackenzie Releases Global Solar Module Manufacturer Ranking
SINGAPORE, Dec. 19, 2025 /PRNewswire/ -- Recently, leading global energy research and consultancy firm Wood Mackenzie released its Global Solar Module Manufacturer Ranking H1 2025. ELITE Solar once again secured a position on this prestigious global...